EIF2AK4 Gene: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:

Eukaryotic translation initiation factor 2 alpha kinase 4

  • genes

1. Normal Function

The EIF2AK4 gene provides instructions for making a protein that helps direct a cell's response to changes that could damage the cell. This protein is found in several tissues throughout the body, including blood vessel walls. The EIF2AK4 protein can turn on (activate) another protein called eIF2 alpha (eIF2α), which helps control protein production. When cells are under stress, for example when the level of protein building blocks (amino acids) is too low, EIF2AK4 activates eIF2α. When turned on, eIF2α stimulates processes that reduce protein production, which helps conserve amino acids. In addition, activated eIF2α can trigger production of certain proteins called transcription factors, which control gene activity. The transcription factors regulated by eIF2α control the activity of genes involved in processes that help reduce the stress on the cell.

2. Health Conditions Related to Genetic Changes

2.1 Pulmonary Veno-Occlusive Disease

Mutations in the EIF2AK4 gene are the primary genetic cause of a condition called pulmonary veno-occlusive disease (PVOD); at least 22 mutations in this gene have been found in affected individuals. In PVOD, excess fibrous tissue builds up in the small vessels in the lungs that carry oxygenated blood from the lungs to the heart (the pulmonary veins). This buildup narrows (occludes) the vessels and impairs blood flow. Because blood flow through the lungs is difficult, pressure rises in the vessels that carry blood that needs to be oxygenated to the lungs from the heart (pulmonary arteries). Increased pressure in these vessels is known as pulmonary arterial hypertension.

The EIF2AK4 gene mutations involved in PVOD likely lead to a complete loss of functional protein. It is not known how absence of EIF2AK4 protein function leads to the pulmonary vein abnormalities characteristic of PVOD.

2.2 Pulmonary Arterial Hypertension

3. Other Names for This Gene

  • E2AK4_HUMAN

  • eukaryotic translation initiation factor 2-alpha kinase 4

  • GCN2

  • GCN2 eIF2alpha kinase

  • GCN2-like protein

  • general control nonderepressible 2

  • KIAA1338

  • PVOD2

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/eif2ak4

References

  1. Deval C, Chaveroux C, Maurin AC, Cherasse Y, Parry L, Carraro V, Milenkovic D,Ferrara M, Bruhat A, Jousse C, Fafournoux P. Amino acid limitation regulates the expression of genes involved in several specific biological processes throughGCN2-dependent and GCN2-independent pathways. FEBS J. 2009 Feb;276(3):707-18.doi: 10.1111/j.1742-4658.2008.06818.x.
  2. Donnelly N, Gorman AM, Gupta S, Samali A. The eIF2α kinases: their structures and functions. Cell Mol Life Sci. 2013 Oct;70(19):3493-511. doi:10.1007/s00018-012-1252-6.
  3. Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N,Coulet F, Bonnet D, Dorfmüller P, Fadel E, Sitbon O, Simonneau G, Tregouët DA,Humbert M, Soubrier F. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet. 2014 Jan;46(1):65-9. doi: 10.1038/ng.2844.
  4. Murguía JR, Serrano R. New functions of protein kinase Gcn2 in yeast andmammals. IUBMB Life. 2012 Dec;64(12):971-4. doi: 10.1002/iub.1090.
More
This entry is offline, you can click here to edit this entry!